Codexis (CDXS) EBT Margin (2010 - 2026)

Codexis (CDXS) recorded quarterly EBT Margin of 56.85% in Q1 2026, down 329.98% quarter-over-quarter from 24.72% in Q4 2025, and up 21727.0% on a YoY basis from N/an in Q1 2025.

Codexis (CDXS) EBT Margin (2010 - 2026) Analysis & Trends

Codexis' EBT Margin history runs 17 years deep, the most recent figure standing at 56.85% for Q1 2026.

  • In Q1 2026, EBT Margin rose 21727.0% year-over-year to 56.85%; the TTM figure through Mar 2026 stood at 40.87% (up 10853.0% YoY), while the FY2025 annual figure was 62.41%, up 4753.0% from the prior year.
  • EBT Margin was 56.85% for Q1 2026 at Codexis, down from 24.72% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 24.72% in Q4 2025 to a low of 376.19% in Q3 2023.
  • Historically, EBT Margin has averaged 131.06% across 5 years, with a median of 86.52% in 2025.
  • The sharpest annual moves came in 2023 and 2026: EBT Margin plunged 34722 bps in 2023, then soared 21727 bps in 2026.
  • A 5-year view of EBT Margin shows it stood at 62.89% in 2022, then tumbled by 128 bps to 143.14% in 2023, then jumped by 66 bps to 48.34% in 2024, then soared by 151 bps to 24.72% in 2025, then tumbled by 330 bps to 56.85% in 2026.
  • The last three EBT Margin figures came in at 56.85% (Q1 2026), 24.72% (Q4 2025), and 227.96% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 6.40%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 41.95%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Codexis 236.00 Mn 170.86 Mn 13.18 Mn -56.85%

Historic Data

Download Data
DateValue
Mar 31, 2026 -56.85%
Dec 31, 2025 24.72%
Sep 30, 2025 -227.96%
Jun 30, 2025 -86.52%
Mar 31, 2025 -274.12%
Dec 31, 2024 -48.34%
Sep 30, 2024 -160.76%
Jun 30, 2024 -285.06%
Mar 31, 2024 -67.33%
Dec 31, 2023 -143.14%
Sep 30, 2023 -376.19%
Jun 30, 2023 -230.28%
Mar 31, 2023 -174.09%
Dec 31, 2022 -62.89%
Sep 30, 2022 -28.96%
Jun 30, 2022 -6.59%
Mar 31, 2022 -23.62%
Dec 31, 2021 -41.31%
Sep 30, 2021 6.40%
Jun 30, 2021 -16.72%